Health Secretary Critiques Pregnant Women’s Protests

During a Cabinet meeting at the White House, Health and Human Services Secretary Robert F. Kennedy Jr. commented on the increasing phenomenon he terms “Trump Derangement Syndrome,” suggesting it’s reached concerning levels. He referenced a trend where pregnant women have been taking Tylenol as a form of protest against President Donald Trump, despite warnings linking the medication to autism.

Kennedy expressed disbelief over what he described as a maternal instinct being overridden. “That a mother could compromise her instincts and potentially endanger her child is alarming,” he remarked.

He mentioned seeing a TikTok video of a pregnant Columbia University professor taking Tylenol in protest, which left him shocked. “It’s troubling,” he said, “to see any mother do this while pregnant, especially knowing the risks involved.”

Kennedy further elaborated on how this behavior is indicative of a larger issue. “It’s pathological that some would resort to this kind of action against Trump,” he asserted. “And it’s becoming prevalent.”

Recently, President Trump pointed out that Tylenol use during pregnancy might significantly increase autism risks. At that same gathering, Kennedy talked about various health organizations working together to understand the autism epidemic and methods for prevention and reversal.

Kennedy criticized traditional research methods, stating that the National Institutes of Health (NIH) has focused too heavily on genetic studies, ignoring factors like environment and medication, which he likened to studying lung cancer without addressing smoking.

In response, Tylenol’s manufacturer Kenview disagreed with the government’s stance, asserting that credible research shows no link between acetaminophen and autism, emphasizing concerns about misleading claims affecting pregnant women.

After Trump’s announcement, many liberal pregnant women began publicly filming themselves taking Tylenol to protest, which has sparked a debate about the responsibility of mothers during pregnancy.

Kennedy expressed his concerns about rising autism rates, referencing historical data from the 1970s where the prevalence was 1 in 20,000 for 8-year-olds, contrasting it with current rates of 1 in 12 for boys. He labeled this trend a “national security issue.”

Trump echoed similar sentiments, implying that something has changed in the environment leading to these rising rates. Kennedy also cited studies linking Tylenol use and autism, including cases involving circumcised boys, suggesting a correlation that warrants further investigation.

Trump underscored the amount of evidence available linking Tylenol to autism, recalling discussions with Kennedy about these concerns that span over two decades. “It seems to be getting worse,” he reflected, emphasizing the urgency of the situation.